Hear about the evolving role of MRI in diagnosing transient ischemic attacks with our insightful conversation from #ESOC2025 with Dr Philipp Bücke of @unibern.🧠😄. Click here to watch:.🎥 #NeuroTwitter #voiceofstroke #StrokeTwitter.

Watch our recent interview with @joaquimjferreir of @ULisboa_.from #EAN2025, to gain insight into the 1.5-yr follow-up of the EPSILON trial investigating opicapone in non-fluctuating #Parkinsons disease:. 🎥 #NeuroTwitter #TrialUpdate #CTSM @EANeurology.

In an interview from #EAN2025, Patrick Cras of @UAntwerpen explores the topic of assisted dying in #dementia & other neurological disorders, with a particular focus on ethical challenges and common misconceptions among clinicians:. 🎥 @EANeurology.

How did Chat-GPT-4o compare with neurologists in the diagnosis and management of real-life polyneuropathy cases?🤔. Alberto De Lorenzo of @LaStatale shared insight into a study investigating this at #EAN2025:. 🎥 @EANeurology #NeuroTwitter #Neurology.

It's always a pleasure to speak with the wonderful @Simona_Sacco_ of @univaq!😄. At #EAN2025, Prof. Sacco discussed the TACTIC trial evaluating the effectiveness of TDCS plus anti-CGRP monoclonal antibodies in #migraine:. 🎥 @EANeurology #headache #CTSM.

Want to hear as @C_OrejaGuevara shares her highlights in #MultipleSclerosis from #EAN2025? 🧠. Make sure to check out our interview with her by clicking here:. 👉 👈. #MS #MultScler #NeuroTwitter #Neurology @EANeurology.

What are some of the benefits of mobile #stroke units (MSUs)?🧠🤔. @VYogendrakumar of @OttawaHospital provided valuable insight into this in an interview at #ESOC2025.🎥. Click here to watch:.👉 #NeuroTwitter #voiceofstroke #StrokeTwitter.

#EAN2025 | David Oliver of @UniKent comments on the complexities of assisted dying for patients with neurological diseases, highlighting the potential vulnerabilities of patients:. 🎥 #NeuroTwitter #Neurology #ALS @EANeurology.

Many thanks to @MessoudAshina for speaking with us recently on the PEARL trial, investigating the real-world effectiveness of fremanezumab for the preventive treatment of migraine. 📹 #headache #neurology #NeuroTwitter #EAN2025.

Want to hear about a pilot prospective observational study that explored the effect of liraglutide, a GLP-1R agonist used to treat obesity, in patients with #migraine?🧠. Watch our interview with Simone Braca of @UninaIT from #EAN2025:. 🎥 @EANeurology.

Thank you to @MRomozzi for stopping by at #EAN2025 to provide insight into a study investigating CGRP levels in the tear fluid as a novel, non-invasive technique in patients with #migraine.🧠. Watch here to find out more:.👉 👈. @EANeurology #headache.

It was fantastic to catch up with @KKRukavina at #EAN2025 to hear about the role of hormonal replacement therapy in female patients with #Parkinsons disease. Check out the interview here:.🎥 #NeuroTwitter #Neurology #MovementDisorders @EANeurology.

RT @VJDementia: Check out our interview with @KrystofB from #EAN2025!🎥. He breaks down the latest advances that are being made in the use o….

At #ESOC2025 last month, we spoke to Dileep Yavagal (@dyavagal) of @umiamimedicine to hear about a Phase I study of PKL-021, a novel matrix metalloproteinase broad-spectrum inhibitor, after ischemic #stroke. Watch here:.👉 @ESOstroke #StrokeTwitter #CTSM.

🎥 @Diana_A_Sousa of @ULisboa_ presents the findings of the EXCOA-CVT randomized trial, which investigated the potential benefit of extending the duration of anticoagulation after cerebral venous thrombosis. Find out more here:.👉 #stroke #ESOC2025.

#ESOC2025 | Santiago Ortega-Gutierrez (@uihealthcare) comments on the simplification of imaging in acute #stroke triage, highlighting the development of artificial intelligence software that simplifies the triage process:. 🎥 @ESOstroke #StrokeTwitter #AI.

#EAN2025 has wrapped up, and we had a fantastic time in Helsinki!. 🎥 Watch our interviews here: More videos coming soon!. Huge thanks to the organizers (@EANeurology) and to all the brilliant experts who joined us on camera. #NeuroTwitter #Neurology

What is the importance of goal setting in rehabilitation after #stroke?🧠🤔. @NatashaLannin of @MonashUni discussed this with us in a fantastic conversation at #ESOC2025 – watch it here:. 👉 #voiceofstroke #StrokeTwitter #NeuroTwitter.

We just had an insightful interview with Prof. Rigmor Højland Jensen on the RESOLUTION trial, which is investigating eptinezumab in chronic migraine and medication-overuse headache, and advances that have been made in cluster headache. #EAN2025 @EANeurology #neurology

Dr Alberto De Lorenzo stopped by at #EAN2025 today to discuss his study investigating the efficacy of Chat-GPT-4o in the diagnosis and management of real-life polyneuropathy cases. How did Chat-GPT-4o compare with neurologists?🤔. Stay tuned on to find